148 related articles for article (PubMed ID: 16984172)
1. Organic azide inhibitors of cysteine proteases.
Le GT; Abbenante G; Madala PK; Hoang HN; Fairlie DP
J Am Chem Soc; 2006 Sep; 128(38):12396-7. PubMed ID: 16984172
[TBL] [Abstract][Full Text] [Related]
2. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
3. Noncovalent tripeptidyl benzyl- and cyclohexyl-amine inhibitors of the cysteine protease caspase-1.
Löser R; Abbenante G; Madala PK; Halili M; Le GT; Fairlie DP
J Med Chem; 2010 Mar; 53(6):2651-5. PubMed ID: 20170165
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase synthesis of azidomethylene inhibitors targeting cysteine proteases.
Yang PY; Wu H; Lee MY; Xu A; Srinivasan R; Yao SQ
Org Lett; 2008 May; 10(10):1881-4. PubMed ID: 18407644
[TBL] [Abstract][Full Text] [Related]
5. Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K.
Marquis RW; Yamashita DS; Ru Y; LoCastro SM; Oh HJ; Erhard KF; DesJarlais RL; Head MS; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; Tomaszek TA; Levy MA; Veber DF
J Med Chem; 1998 Sep; 41(19):3563-7. PubMed ID: 9733481
[No Abstract] [Full Text] [Related]
6. Inhibition of interleukin-1beta converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones.
Galatsis P; Caprathe B; Downing D; Gilmore J; Harter W; Hays S; Kostlan C; Linn K; Lunney E; Para K; Thomas A; Warmus J; Allen H; Brady K; Talanian R; Walker N
Bioorg Med Chem Lett; 2010 Sep; 20(17):5089-94. PubMed ID: 20674352
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks.
Schirmeister T
Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of cysteine proteases.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
[TBL] [Abstract][Full Text] [Related]
9. Benzodioxocin-3-ones and N-acyl-3-amino-3-buten-2-ones: novel classes of cathepsin K cysteine protease inhibitors.
Yamashita DS; Xie R; Lin H; Wang B; Shi SD; Quinn CJ; Hemling ME; Hissong C; Tomaszek TA; Veber DF
J Pept Res; 2004 Mar; 63(3):265-9. PubMed ID: 15049838
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
[TBL] [Abstract][Full Text] [Related]
11. Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.
Perlman N; Hazan M; Shokhen M; Albeck A
Bioorg Med Chem; 2008 Oct; 16(19):9032-9. PubMed ID: 18789705
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P2 alpha-amino acid by a alpha-hydroxy acid.
Wang Y; Guan L; Jia S; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2005 Mar; 15(5):1379-83. PubMed ID: 15713391
[TBL] [Abstract][Full Text] [Related]
13. Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1).
Galatsis P; Caprathe B; Gilmore J; Thomas A; Linn K; Sheehan S; Harter W; Kostlan C; Lunney E; Stankovic C; Rubin J; Brady K; Allen H; Talanian R
Bioorg Med Chem Lett; 2010 Sep; 20(17):5184-90. PubMed ID: 20656488
[TBL] [Abstract][Full Text] [Related]
14. Theoretical studies of binding modes of two covalent inhibitors of cysteine proteases.
Drabik P; Politowska E; Czaplewski C; Kasprzykowski F; Lankiewicz L; Ciarkowski J
Acta Biochim Pol; 2000; 47(4):1061-6. PubMed ID: 11996096
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.
James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341
[TBL] [Abstract][Full Text] [Related]
17. Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Ray JA; Samano V; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
Bioorg Med Chem Lett; 2006 Mar; 16(6):1735-9. PubMed ID: 16376075
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S.
Thurmond RL; Beavers MP; Cai H; Meduna SP; Gustin DJ; Sun S; Almond HJ; Karlsson L; Edwards JP
J Med Chem; 2004 Sep; 47(20):4799-801. PubMed ID: 15369380
[TBL] [Abstract][Full Text] [Related]
19. Uncovering false positives on a virtual screening search for cruzain inhibitors.
Malvezzi A; de Rezende L; Izidoro MA; Cezari MH; Juliano L; do Amaral A
Bioorg Med Chem Lett; 2008 Jan; 18(1):350-4. PubMed ID: 17981033
[TBL] [Abstract][Full Text] [Related]
20. Rhenium inhibitors of cathepsin B (ReO(SYS)X (where Y = S, py; X = Cl, Br, SPhOMe-p)): Synthesis and mechanism of inhibition.
Mosi R; Baird IR; Cox J; Anastassov V; Cameron B; Skerlj RT; Fricker SP
J Med Chem; 2006 Aug; 49(17):5262-72. PubMed ID: 16913715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
